Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
500.00    0.00 (0.00%)
Bid:
499.80
Ask:
500.50
Spread: 0.70 (0.14%)
Market Cap: £1.35b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

CONTRACT AWARDS

20 Dec 2012 07:00

RNS Number : 9754T
Chemring Group PLC
20 December 2012
 



FOR IMMEDIATE RELEASE 20 December 2012

 

 

CHEMRING GROUP PLC

 NIITEK AWARDED $32 MILLION ADDITIONAL HMDS IDIQ DELIVERY ORDERS

 

Chemring Group PLC ("Chemring") is pleased to announce that its US subsidiary, Non-Intrusive Inspection Technology, Inc. ("NIITEK"), has been awarded two additional delivery orders totaling $32 million to provide spares for both the US Army and US Marine Corps. These delivery orders are issued as part of the multi-year Husky Mounted Detection System ("HMDS") Ground Penetrating Radar ("GPR") Indefinite-Delivery/Indefinite-Quantity ("IDIQ") contract that was awarded on 30 April 2012. This contract not only provides the US Army with the ability to procure spares and replacement systems to replenish theatre sustainment stock, but also provides the ability to serve future system requirements for the US Marine Corps and potential Foreign Military Sales. The potential value of the IDIQ contract is $579 million, with performance into 2013.

Mark Papworth, Chief Executive of Chemring, commented:

"We are delighted that these additional delivery orders enable us to continue our vital support to the US Army and US Marine Corps with NIITEK's HMDS products. Since the inception of the HMDS over four years ago, our commitment remains to provide the best explosives and mine detection capability to US and coalition forces currently in combat, as well as looking ahead to support them as they stand ready to conduct operations around the world."

-ENDS-

 

Chemring Group PLC

Rupert Pittman Director of Communications and Investor Relations

01489 881 880 / rupertp@chemring.co.uk

 

MHP Communications

Andrew Jaques / James White

0203 128 8100

 

Notes to Editors:

Chemring is a market leading manufacturing business supplying high technology electronics and energetic products to over eighty countries around the world. Chemring has a diverse portfolio of products that predominantly protect military people and platforms, providing insurance against a constantly changing threat. These range from countermeasures to protect aircraft, to ground penetrating radar to protect troops and vehicles from improvised explosive devices. NIITEK, a Chemring company since 2008, is the world leader in the design, development and production of Advanced Ground Penetrating Radar ("GPR") systems. NIITEK's Advanced GPR systems are at the leading edge of mine detection technology with over two hundred systems successfully being used by US and Coalition forces in Afghanistan.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFFLEFUFESEIE
Date   Source Headline
1st May 201810:26 amRNSTotal Voting Rights
1st May 20187:00 amRNSDirectorate Change
27th Apr 20183:41 pmRNSHolding(s) in Company
23rd Apr 201811:55 amRNSHolding(s) in Company
19th Apr 20187:00 amRNSContract Award
3rd Apr 20181:03 pmRNSTotal Voting Rights
23rd Mar 20187:00 amRNSChange of auditor
20th Mar 20182:17 pmRNSResult of AGM
20th Mar 20187:00 amRNSAGM Statement
1st Mar 201811:02 amRNSTotal Voting Rights
23rd Feb 201810:35 amRNSHolding(s) in Company
15th Feb 201810:23 amRNSNotice of AGM
8th Feb 20184:27 pmRNSHolding(s) in Company
5th Feb 201812:10 pmRNSHolding(s) in Company
1st Feb 201810:51 amRNSTotal Voting Rights
1st Feb 20187:00 amRNSContract Award
29th Jan 20185:38 pmRNSHolding(s) in Company
29th Jan 20182:30 pmRNSDirector/PDMR Shareholding
29th Jan 20182:28 pmRNSDirector/PDMR Shareholding
29th Jan 20182:25 pmRNSDirector/PDMR Shareholding
29th Jan 20182:25 pmRNSDirector/PDMR Shareholding
29th Jan 20181:47 pmRNSDirector/PDMR Shareholding
29th Jan 20181:43 pmRNSDirector/PDMR Shareholding
29th Jan 20181:38 pmRNSDirector/PDMR Shareholding
29th Jan 20181:38 pmRNSDirector/PDMR Shareholding
29th Jan 201810:46 amRNSTransaction in Own Shares
29th Jan 201810:23 amRNSTransaction in Own Shares
26th Jan 201812:32 pmRNSHolding(s) in Company
26th Jan 201812:26 pmRNSHolding(s) in Company
23rd Jan 201810:41 amRNSHolding(s) in Company
22nd Jan 201810:11 amRNSDirector/PDMR Shareholding
22nd Jan 201810:08 amRNSDirector/PDMR Shareholding
22nd Jan 201810:03 amRNSDirector/PDMR Shareholding
22nd Jan 201810:02 amRNSDirector/PDMR Shareholding
22nd Jan 201810:00 amRNSDirector/PDMR Shareholding
22nd Jan 201810:00 amRNSDirector/PDMR Shareholding
18th Jan 20187:00 amRNSFULL YEAR RESULTS
3rd Jan 20189:59 amRNSBlock listing Interim Review
2nd Jan 20189:55 amRNSTotal Voting Rights
19th Dec 201710:30 amRNSHolding(s) in Company
19th Dec 201710:21 amRNSHolding(s) in Company
14th Dec 20175:09 pmRNSHolding(s) in Company
11th Dec 201711:26 amRNSHolding(s) in Company
1st Dec 20179:43 amRNSTotal Voting Rights
27th Nov 201711:05 amRNSHolding(s) in Company
14th Nov 20177:00 amRNSPOST-CLOSE STATEMENT
1st Nov 20179:05 amRNSTotal Voting Rights
30th Oct 20174:02 pmRNSHolding(s) in Company
27th Oct 20171:03 pmRNSHolding(s) in Company
27th Oct 201710:10 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.